Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
Operating Expenses | 5,549 | 6,896 | 247 | 5,912 | 4,927 |
Operating Income | -5,549 | -6,896 | -247 | -5,912 | -4,927 |
Other Income | -290 | 86 | 1,160 | -1,528 | 1,182 |
Pre-tax Income | -5,839 | -6,810 | 914 | -7,440 | -3,745 |
Net Income Continuous | -5,839 | -6,810 | 914 | -7,440 | -3,745 |
Net Income | $-5,839 | $-6,810 | $914 | $-7,440 | $-3,745 |
EPS Basic Total Ops | -3.00 | -12.60 | 0.60 | -5.00 | -3.00 |
EPS Basic Continuous Ops | -3.04 | -3.42 | 0.54 | -4.96 | -2.98 |
EPS Diluted Total Ops | -3.00 | -12.60 | 0.60 | -5.00 | -3.00 |
EPS Diluted Continuous Ops | -3.04 | -3.42 | 0.54 | -4.96 | -2.98 |
EBITDA(a) | $-5,548 | $-6,895 | $-246 | $-5,909 | $-4,923 |